financetom
Business
financetom
/
Business
/
Progress Software Shows Steady Q2 Execution, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Progress Software Shows Steady Q2 Execution, Oppenheimer Says
Jul 1, 2025 12:05 PM

02:52 PM EDT, 07/01/2025 (MT Newswires) -- Progress Software ( PRGS ) posted strong Q2 results, driven by steady demand across the business including strength in the data platform portfolio, Oppenheimer said in a Tuesday note.

"Progress delivered a solid quarter as it effectively balances the

integration of ShareFile...with continued deleveraging," it said.

The report added that the firm continues to operate at a high level and is integrating ShareFile ahead of plan. It also pointed to a rise in FY25 guidance for revenue, EPS, and cash flow.

"We're positive on steady execution and the newly announced acquisition of Nuclia, seeing potential for accelerated cross-sell and improved net retention once fully integrated," the note said.

Oppenheimer kept its outperform rating and $80 price target.

Price: 55.88, Change: -7.96, Percent Change: -12.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Ideaya Biosciences Begins Phase 1/2 Expansion in Urothelial Cancer Treatment Trial in Combination With Gilead's Trodelvy
Ideaya Biosciences Begins Phase 1/2 Expansion in Urothelial Cancer Treatment Trial in Combination With Gilead's Trodelvy
Apr 10, 2025
07:18 AM EDT, 04/10/2025 (MT Newswires) -- Ideaya Biosciences ( IDYA ) said Thursday it launched a phase 1/2 expansion in a clinical trial of its experimental IDE397 treatment in combination with Gilead Sciences' ( GILD ) Trodelvy in methylthioadenosine phosphorylase, or MTAP-deletion urothelial cancer, based on preliminary safety and clinical efficacy data. The prevalence of MTAP-deletion is estimated at...
Descartes Says Air Messaging Solution Streamlines Air Shipment Data Exchange with IATA's ONE Record
Descartes Says Air Messaging Solution Streamlines Air Shipment Data Exchange with IATA's ONE Record
Apr 10, 2025
07:22 AM EDT, 04/10/2025 (MT Newswires) -- Descartes Systems Group ( DSGX ) said Thursday its Air Messaging solution has streamlined the transmission of air shipment data, according to the International Air Transport Association's (IATA) ONE Record messaging standard. IATA's ONE Record initiative aims to help airlines, their partners and service providers digitize air cargo messaging services by January 1,...
Bombardier Says New Service Facility to Relocate to Al Bateen Executive Airport in Abu Dhabi
Bombardier Says New Service Facility to Relocate to Al Bateen Executive Airport in Abu Dhabi
Apr 10, 2025
07:24 AM EDT, 04/10/2025 (MT Newswires) -- Aircraft maker Bombardier (BBD-A.TO, BBD-B.TO) overnight Wednesday said its new service facility will relocate to the Al Bateen Executive Airport in Abu Dhabi, United Arab Emirates, from its originally announced location at the Abu Dhabi International Airport. This move represents a strategic alignment, given the airport's dedicated focus on business aviation and its...
Copyright 2023-2026 - www.financetom.com All Rights Reserved